Cargando…

Venous thromboembolism in critically ill patients with pneumonia in the pre‐COVID‐19 era: Data from a large public database

BACKGROUND: The magnitude of venous thromboembolism (VTE) risk in severe COVID‐19 is a matter of debate because of study heterogeneity, changes in VTE management, and scarce evidence of VTE risk in critically ill patients with pneumonia in the pre‐COVID‐19 era. OBJECTIVES: To evaluate VTE risk in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pisani, Miguel, Orsi, Fernanda A., Annichino‐Bizzacchi, Joyce M., Barco, Stefano, De Paula, Erich V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548411/ https://www.ncbi.nlm.nih.gov/pubmed/36246480 http://dx.doi.org/10.1002/rth2.12816

Ejemplares similares

Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism
por: Bittar, Luis F., et al.
Publicado: (2015)

Principal Component Analysis on Recurrent Venous Thromboembolism
por: Martins, Tiago D., et al.
Publicado: (2019)

Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event
por: Zapponi, Kiara C. S., et al.
Publicado: (2021)

CD144, CD146 and VEGFR-2 properly identify circulating endothelial cell
por: Flores-Nascimento, Mariane Cristina, et al.
Publicado: (2015)

Venous thromboembolism in childhood: where is Brazil after 20 years?
por: Mello, Tayana Teixeira, et al.
Publicado: (2020)

Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case–control study comparing dengue fever patients with and without bleeding manifestations
por: Orsi, Fernanda A, et al.
Publicado: (2013)

Prophylaxis and treatment of venous thromboembolism in the critically ill
por: Adriance, Sarah M, et al.
Publicado: (2013)

Gene Variants Associated With Venous Thrombosis: A Replication Study in a Brazilian Multicentre Study
por: Romano, Anna Virgínia Calazans, et al.
Publicado: (2020)

Venous Thromboembolism in Critical Illness and Trauma: Pediatric Perspectives
por: Chima, Ranjit S., et al.
Publicado: (2017)

A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response
por: Colella, Marina P., et al.
Publicado: (2021)

Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism
por: Perrella, Alessandro, et al.
Publicado: (2021)

Venous thromboembolism in critically ill patients: incidence and risk factors
por: Al-Qahtani, S, et al.
Publicado: (2007)

Hemorrhage and venous thromboembolism in critically ill patients with COVID-19
por: Qiu, Chenyang, et al.
Publicado: (2021)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
por: Verma, Karan, et al.
Publicado: (2017)

Effectiveness of Sequential Compression Devices in Prevention of Venous Thromboembolism in Medically Ill Hospitalized Patients: A Retrospective Cohort Study
por: Dhakal, Prajwal, et al.
Publicado: (2019)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Prevalence of the MTHFR C677T Mutation in Fertile and Infertile Women
por: Soligo, Adriana de Góes, et al.
Publicado: (2017)

Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective
por: Fiusa, Maiara Marx Luz, et al.
Publicado: (2015)

Venous Thromboembolism in Critically Ill Cirrhotic Patients: Practices of Prophylaxis and Incidence
por: Al-Dorzi, Hasan M., et al.
Publicado: (2013)

Venous thromboembolism in non-critically ill patients with COVID-19 infection
por: Trimaille, Antonin, et al.
Publicado: (2020)

Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients
por: Dujardin, Romein W.G., et al.
Publicado: (2020)

Venous thromboembolism in non-critically ill patients with COVID-19 infection
por: Trimaille, A., et al.
Publicado: (2021)

Postdischarge venous thromboembolism following hospital admission with COVID-19
por: Roberts, Lara N., et al.
Publicado: (2020)

Venous thromboembolism in patients hospitalized for knee joint replacement surgery
por: Keller, Karsten, et al.
Publicado: (2020)

Folate, Vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center
por: Barnabé, Aline, et al.
Publicado: (2015)

A case series of platelet rich plasma in chronic venous ulcers
por: Huber, Stephany Cares, et al.
Publicado: (2021)

Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition
por: Mavromanoli, Anna C., et al.
Publicado: (2021)

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer
por: Anijs, Rayna J. S., et al.
Publicado: (2022)

Outcomes in infants with unprovoked venous thromboembolism: A retrospective cohort study
por: Whitworth, Hilary, et al.
Publicado: (2023)

Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey
por: Cook, Deborah, et al.
Publicado: (2001)

Incidence, risk factors and outcome of venous thromboembolism in critically ill obstetric patients
por: Kaddour, C, et al.
Publicado: (2008)

Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
por: Orsi, Fernanda Andrade, et al.
Publicado: (2020)

The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients
por: Boyd, Sean, et al.
Publicado: (2021)

Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome
por: Bittar, Luis Fernando, et al.
Publicado: (2020)

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study
por: Forté, Stéphanie, et al.
Publicado: (2022)

Correction to: The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients
por: Boyd, Sean, et al.
Publicado: (2022)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants
por: Qureshi, Waqas, et al.
Publicado: (2016)

The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in medical and critically ill patients
por: Al-Hameed, Fahad M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6s5uem7ga75asgs9p55vcnrk3n